Clinical Trials
4 trialsNCT05063565 2026-04-29
ROWAN
Boston Scientific Corporation
Phase 2 Active not recruiting
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT04707547 2021-01-13
RFA
Taipei Medical University WanFang Hospital
Phase 4 Completed
NCT02989870 2020-06-05
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Withdrawn